Talus Bio
Private Company
Gene regulator profiling in live cells for drug development
Biotechnology Research
Seattle, WA
11-50 employees
Founded Jul 2020
About Talus Bio
Talus Bio is a biotechnology firm dedicated to unlocking the therapeutic potential of gene regulation with peptide-based medicines. The company offers its proprietary AI-driven MARMOT platform and proteomics services to pharmaceutical developers and researchers, enabling the discovery of new therapeutics for challenging cancers and genetic diseases.
Company Classification
Customer Types
B2B
Business Models
ProductsServicesLicensing
Product & Service Types
AI-driven drug discovery platformTherapeutic compound librariesProteomics research services
Funding
Total Funding
$27.78M
No. of Funding Rounds
10
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos